White Papers & eBooks
Explore a selection of standard and long-form articles below.
Whitepapers
Driving Sustainability in the IVD Industry: Key Market Trends and Strategic Approaches
(Published March 25, 2025)
Sustainability is becoming an important priority in diagnostic testing as healthcare systems work to reduce environmental impact. This paper explores how the life sciences industry is adopting practices and technologies that minimize waste and support more sustainable diagnostic development.
Saliva Specimen-specificTM Master Mixes for Multiplex Assays Using Crude Samples
(Published September 12, 2022)
Saliva has emerged as a valuable non-invasive specimen for molecular diagnostics, particularly during the COVID-19 pandemic when large-scale testing was required. While nasopharyngeal swabs remain the standard for respiratory virus detection, their collection requires trained personnel and can create bottlenecks. In contrast, saliva can be easily self-collected, enabling scalable, high-throughput screening.
From Single Mutations to Whole Genomes: Molecular Technologies Shaping Precision Oncology Diagnostics
(Published June 25, 2025)
Molecular diagnostics now play a central role in precision oncology, supporting tumor profiling, minimal residual disease monitoring, and personalized treatment decisions. This paper compares qPCR, targeted next-generation sequencing, and whole genome sequencing, outlining how each technology contributes to modern cancer diagnostics.
Advances in qPCR-based Liquid Biopsy for Cancer Detection & Its Applications
(Published May 21, 2025)
Advances in molecular diagnostics are transforming how cancer is detected and monitored. Liquid biopsy enables non-invasive detection of tumor-derived biomarkers—including circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), proteins, and exosomes—from blood and other body fluids, providing insights into disease progression and treatment response.
Benefits of Multiplex Testing for the Differential Diagnosis of COVID-19, Flu and RSV in a Busy Flu Season
(Published Feb 9, 2022)
Multiplex and syndromic testing allow multiple respiratory pathogens to be detected from a single sample, enabling faster differential diagnosis of diseases with similar symptoms. This approach supports timely clinical decision-making and more efficient use of diagnostic resources.
Direct detection from crude cell lysate: Expression Analysis of Genetic Markers Related to Obesity and Type-2 Diabetes
(Published June 6, 2023)
Gene expression analysis using RT-qPCR typically involves a multi-step workflow, including RNA isolation and purification, which can limit throughput. This white paper explores an alternative approach in which cDNA is synthesized directly from crude cell lysates, enabling streamlined gene expression analysis while reducing time, cost, and contamination risk.
eBooks
From Sample to Insight Technologies Driving the Future of Precision Oncology Assays
(Published September 23, 2025)
Molecular diagnostics are central to precision oncology, enabling tumor profiling, treatment selection, and disease monitoring. This paper examines how qPCR, targeted next-generation sequencing, and whole-genome sequencing support more accurate and personalized cancer diagnostics.
The Evolution of STI Testing: A Catalyst for Modern Diagnostic Technologies
(Published February 2, 2026)
Sexually transmitted infections remain a significant global health challenge, driving growing demand for accessible and reliable diagnostics. This eBook explores how advances in molecular testing, point-of-care diagnostics, and at-home collection models are reshaping STI detection and expanding access to care.